Impedimed Ltd

  • IPO date: 2007-10-24
  • Sector: Healthcare
  • GIC Group: Health Care Equipment & Services
  • Industry: Medical Devices
  • Company website

Company description

ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.

Financial highlights

Market Capitalization$363.3807 million
P/E Ratio0
P/E Growth Ratio0
Book Value0.03
Dividend Per Share0
Earnings Per Share-0.01
EBITDA-22,187
Profit Margin-1.809
Operating Margin TTM-2.0156
Return on Assets TTM-0.2243
Return on Equity TTM-0.3667
Revenue TTM11,344

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
2005-06-30 281 155
2006-06-30 1,071 2,068
2007-06-30 1,214 629
2008-06-30 2,341.482 693.601 1,647.881 11,456.813
2009-06-30 2,991.953 1,427.31 1,564.643 15,729.921
2010-06-30 3,639 1,609 2,030 13,722
2011-06-30 3,887 1,656 2,231 17,485
2012-06-30 2,945 1,265 1,680 15,145
2013-06-30 2,733 1,174 1,559 11,063
2014-06-30 3,521 1,366 2,155 10,157
2015-06-30 4,844 1,290 3,554 18,699
2016-06-30 5,791 1,583 4,208 30,387
2017-06-30 5,766 1,489 4,277 35,029
2018-06-30 4,797 1,596 3,201 33,840
2019-06-30 4,098 1,252 2,846 29,858
2020-06-30 5,694 1,678 4,016 29,573
2021-06-30 8,353 1,602 6,751 29,824
2022-06-30 10,495 1,709 8,786 30,323
2023-06-30 11,249 1,546 9,703 32,696

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
2006-06-30 4,630 9,309 149 7,634
2007-06-30 16,265.52 21,788.942 2,385.405 711.426 64 49,573.105
2008-06-30 8,485.169 14,515.036 2,214.667 64.024 50,809.291
2009-06-30 6,633.641 13,097.976 3,030.872 61,484.475
2010-06-30 18,789 24,910 2,680 84,559
2011-06-30 17,930 22,805 2,122 98,004
2012-06-30 14,545 19,614 2,304 106,102
2013-06-30 7,316 11,864 1,270 106,101
2014-06-30 10,812 14,958 1,426 116,593
2015-06-30 32,582 37,917 3,080 147,349
2016-06-30 82,254 90,570 5,316 218,807
2017-06-30 54,884 64,343 5,546 0 219,493
2018-06-30 31,345 41,767 5,765 0 219,746
2019-06-30 11,330 22,581 6,796 0 219,727
2020-06-30 19,663 33,064 5,703 364 250,563
2021-06-30 19,681 34,205 8,691 315 267,268
2022-06-30 40,730 58,699 7,655 170 307,558
2023-06-30 45,710 68,736 7,857 300 336,087

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
2006-06-30
2007-06-30 1,612.462
2008-06-30 -9,754.128 -7,416.381 6,842.007 1,612.462 8,454.469
2009-06-30 -14,027.655 -11,786.199 -1,820.828 8,454.469 6,633.641
2010-06-30 -11,402 -10,386 12,155 6,634 18,789
2011-06-30 -14,822 -11,299 -890 18,789 17,899
2012-06-30 -12,342 -11,797 -3,385 17,899 14,514
2013-06-30 -8,464 -7,675 -7,198 14,514 7,316
2014-06-30 -7,935 -6,802 3,496 7,316 10,812
2015-06-30 -14,797 -10,757 21,770 10,812 32,582
2016-06-30 -25,980 -22,422 49,672 32,582 82,254 0
2017-06-30 -27,571 -25,566 -27,370 82,254 54,884 0
2018-06-30 -27,174 -23,458 -23,539 54,884 31,345
2019-06-30 -23,996 -19,588 -20,015 31,345 11,330
2020-06-30 -21,377 -19,218 8,333 11,330 19,663
2021-06-30 -20,706 -13,258 18 19,663 19,681 580
2022-06-30 -19,874 -17,105 21,049 19,681 40,730
2023-06-30 -20,521 -18,049 4,980 40,730 45,710